SARS-CoV-2 Vaccines Development: Inactivated Vaccines

cPass™ SARS-CoV-2 Neutralizing Antibody test for vaccine development and immunity status monitoringПодробнее

Dan Barouch: "Covid-19 Vaccine Development" (12/1/21)Подробнее

Overcoming Key Challenges in Vaccine DevelopmentПодробнее

The Types, Effectiveness and Safety of Vaccines to Prevent SARS-CoV-2 Infection - Bradley AckersonПодробнее

SARS-Cov2 ,COVID19, Coronna Virus VaccinesПодробнее

Types of vaccines and how they work, efficacy/effectivenessПодробнее

KNH-UoN Webinar : The Science of Vaccines(SARS COV-2 COVID-19)Подробнее

Enhancing strategies for COVID-19 solutions in diagnosis, vaccine development and therapiesПодробнее

COVID-19 : Vaccine Development & ChallengesПодробнее

Rajan Sampat- mRNA Vaccine Development for SARS-CoV-2Подробнее

SARS-CoV-2 Vaccines Development: Monoclonal AntibodiesПодробнее

Vaccines for SARS CoV2 (Pandya)Подробнее

SARS-CoV-2 Inactivated Vaccines: Evidence-Based Health Information Related to COVID-19Подробнее

Webinar #5 - SARS-CoV-2 Vaccines: Reality and ExpectationsПодробнее

Considering frailty in SARS-COV-2 vaccine development - Video abstract [ID 295522]Подробнее

SARS-CoV-2 Vaccination in Children - Dr. Anderson (Atlanta)Подробнее

NISS-Merck Meet-up on SARS-COV2 Vaccine Development, January, 2021Подробнее

How do the leading COVID-19 vaccines work?Подробнее

SARS-CoV-2 Vaccines- General Information: Evidence-Based Health Information Related to COVID-19Подробнее

PHYL 142 | Immune | Vaccine Development & Inactivated Virus VaccinesПодробнее